文献速递临床试验与 GCP流行病学与生物统计

综合诊断工具、临床算法及培训沟通对中低收入国家门诊急性发热病例管理影响的随机对照试验方案

Impact of a package of diagnostic tools, clinical algorithm, and training and communication on outpatient acute fever case management in low- and middle-income countries: protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2020-11-25

该研究为随机对照试验方案,旨在评估综合干预包(快速诊断测试、临床算法、培训与沟通)对中低收入国家门诊急性发热患者的临床结局和抗生素处方率的影响。研究在六个国家的九个站点开展,计划至少纳入21876名患者,并进行汇总数据分析。

要点

  • 干预包包括病原体特异和非特异快速诊断测试、临床算法及培训沟通。
  • 主要结局为临床结局改善和减少不必要的抗生素处方。
  • 研究覆盖布基纳法索、加纳、印度、缅甸、尼泊尔和乌干达的九个门诊站点。

核心结论

  • 该试验旨在验证综合干预包能否改善中低收入国家门诊急性发热患者的临床结局并减少抗生素处方。

研究设计与样本

  • 随机对照临床试验,在六个国家的九个门诊站点开展,招募期12个月以覆盖季节性变化。
  • 总体至少纳入21876名患者,完成时进行汇总数据Meta分析。

主要发现

  • 原文未报告结果,仅描述研究方案。

关键数值与推荐

  • 干预包包含基于预设标准选择的现有点诊快速诊断测试(病原体特异和非特异宿主标志物)。
  • 诊断算法和快速诊断测试选择参考各国急性发热病因的现有数据。

临床怎么用

  • 原文未报告临床实践推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The management of acute febrile illnesses places a heavy burden on clinical services in many low- and middle-income countries (LMICs). Bacterial and viral aetiologies of acute fevers are often clinically indistinguishable and, in the absence of diagnostic tests, the 'just-in-case' use of antibiotics by many health workers has become common practice, which has an impact on drug-resistant infections. Our study aims to answer the following question: in patients with undifferentiated febrile illness presenting to outpatient clinics/peripheral health centres in LMICs, can we demonstrate an improvement in clinical outcomes and reduce unnecessary antibiotic prescription over current practice by using a combination of simple, accurate diagnostic tests, clinical algorithms, and training and communication (intervention package)? METHODS: We designed a randomized, controlled clinical trial to evaluate the impact of our intervention package on clinical outcomes and antibiotic prescription rates in acute febrile illnesses. Available, point-of-care, pathogen-specific and non-pathogen specific (host markers), rapid diagnostic tests (RDTs) included in the intervention package were selected based on pre-defined criteria. Nine clinical study sites in six countries (Burkina Faso, Ghana, India, Myanmar, Nepal and Uganda), which represent heterogeneous outpatient care settings, were selected. We considered the expected seasonal variations in the incidence of acute febrile illnesses across all the sites by ensuring a recruitment period of 12 months. A master protocol was developed and adapted for country-specific ethical submissions. Diagnostic algorithms and choice of RDTs acknowledged current data on aetiologies of acute febrile illnesses in each country. We included a qualitative evaluation of drivers and/or deterrents of uptake of new diagnostics and antibiotic use for acute febrile illnesses. Sample size estimations were based on historical site data of antibiotic prescription practices for malarial and non-malarial acute fevers. Overall, 9 semi-independent studies will enrol a minimum of 21,876 patients and an aggregate data meta-analysis will be conducted on completion. DISCUSSION: This study is expected to generate vital evidence needed to inform policy decisions on the role of rapid diagnostic tests in the clinical management of acute febrile illnesses, with a view to controlling the rise of antimicrobial resistance in LMICs. TRIAL REGISTRATION: Clinicaltrials.gov NCT04081051 . Registered on 6 September 2019. Protocol version 1.4 dated 20 December 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Salami O, Horgan P, Moore CE, et al. Impact of a package of diagnostic tools, clinical algorithm, and training and communication on outpatient acute fever case management in low- and middle-income countries: protocol for a randomized controlled trial. Trials. 2020. PMID: 33239106. doi:10.1186/s13063-020-04897-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。